The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Genetic Engineering Drug-Global Market Insights and Sales Trends 2025

Genetic Engineering Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1814480

No of Pages : 94

Ask Your Query
Synopsis
Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.
The global Genetic Engineering Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genetic Engineering Drug in various end use industries. The expanding demands from the Medicine, Research, Industrial and Agriculture, are propelling Genetic Engineering Drug market. Monoclonal Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Human Erythropoietin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genetic Engineering Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genetic Engineering Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genetic Engineering Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genetic Engineering Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genetic Engineering Drug covered in this report include Shanghai Lansheng Guojian Pharmaceutical, Biotech Pharmaceutical, Anhui Anke Biotechnology, GeneScience Pharmaceuticals, Beijing SL Pharmaceutical, Jiangsu Sihuan Bioengineering, Shenzhen Neptunus Interlong Bio-Technique, 3SBio and Tonghua Dongbao Pharmaceutical, etc.
The global Genetic Engineering Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shanghai Lansheng Guojian Pharmaceutical
Biotech Pharmaceutical
Anhui Anke Biotechnology
GeneScience Pharmaceuticals
Beijing SL Pharmaceutical
Jiangsu Sihuan Bioengineering
Shenzhen Neptunus Interlong Bio-Technique
3SBio
Tonghua Dongbao Pharmaceutical
Global Genetic Engineering Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genetic Engineering Drug market, Segment by Type:
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
Global Genetic Engineering Drug market, by Application
Medicine
Research
Industrial
Agriculture
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Genetic Engineering Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Genetic Engineering Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Genetic Engineering Drug Market Overview
1.1 Genetic Engineering Drug Product Overview
1.2 Genetic Engineering Drug Market Segment by Type
1.2.1 Monoclonal Antibody
1.2.2 Recombinant Human Erythropoietin
1.2.3 Recombinant Human Interferon
1.2.4 Recombinant Human Growth Hormone
1.2.5 Recombinant Human Insulin
1.3 Global Genetic Engineering Drug Market Size by Type
1.3.1 Global Genetic Engineering Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Genetic Engineering Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Genetic Engineering Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Genetic Engineering Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Genetic Engineering Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Genetic Engineering Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Genetic Engineering Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Genetic Engineering Drug Sales Breakdown by Type (2018-2023)
2 Global Genetic Engineering Drug Market Competition by Company
2.1 Global Top Players by Genetic Engineering Drug Sales (2018-2023)
2.2 Global Top Players by Genetic Engineering Drug Revenue (2018-2023)
2.3 Global Top Players by Genetic Engineering Drug Price (2018-2023)
2.4 Global Top Manufacturers Genetic Engineering Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Genetic Engineering Drug Market Competitive Situation and Trends
2.5.1 Genetic Engineering Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Genetic Engineering Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetic Engineering Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Genetic Engineering Drug Market
2.8 Key Manufacturers Genetic Engineering Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Genetic Engineering Drug Status and Outlook by Region
3.1 Global Genetic Engineering Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Genetic Engineering Drug Historic Market Size by Region
3.2.1 Global Genetic Engineering Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Genetic Engineering Drug Sales in Value by Region (2018-2023)
3.2.3 Global Genetic Engineering Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Genetic Engineering Drug Forecasted Market Size by Region
3.3.1 Global Genetic Engineering Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Genetic Engineering Drug Sales in Value by Region (2024-2029)
3.3.3 Global Genetic Engineering Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Genetic Engineering Drug by Application
4.1 Genetic Engineering Drug Market Segment by Application
4.1.1 Medicine
4.1.2 Research
4.1.3 Industrial
4.1.4 Agriculture
4.1.5 Other
4.2 Global Genetic Engineering Drug Market Size by Application
4.2.1 Global Genetic Engineering Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Genetic Engineering Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Genetic Engineering Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Genetic Engineering Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Genetic Engineering Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Genetic Engineering Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Genetic Engineering Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Genetic Engineering Drug Sales Breakdown by Application (2018-2023)
5 North America Genetic Engineering Drug by Country
5.1 North America Genetic Engineering Drug Historic Market Size by Country
5.1.1 North America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Genetic Engineering Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Genetic Engineering Drug Sales in Value by Country (2018-2023)
5.2 North America Genetic Engineering Drug Forecasted Market Size by Country
5.2.1 North America Genetic Engineering Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Genetic Engineering Drug Sales in Value by Country (2024-2029)
6 Europe Genetic Engineering Drug by Country
6.1 Europe Genetic Engineering Drug Historic Market Size by Country
6.1.1 Europe Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Genetic Engineering Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Genetic Engineering Drug Sales in Value by Country (2018-2023)
6.2 Europe Genetic Engineering Drug Forecasted Market Size by Country
6.2.1 Europe Genetic Engineering Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Genetic Engineering Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Genetic Engineering Drug by Region
7.1 Asia-Pacific Genetic Engineering Drug Historic Market Size by Region
7.1.1 Asia-Pacific Genetic Engineering Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Genetic Engineering Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Genetic Engineering Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Genetic Engineering Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Genetic Engineering Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Genetic Engineering Drug Sales in Value by Region (2024-2029)
8 Latin America Genetic Engineering Drug by Country
8.1 Latin America Genetic Engineering Drug Historic Market Size by Country
8.1.1 Latin America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Genetic Engineering Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Genetic Engineering Drug Sales in Value by Country (2018-2023)
8.2 Latin America Genetic Engineering Drug Forecasted Market Size by Country
8.2.1 Latin America Genetic Engineering Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Genetic Engineering Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Genetic Engineering Drug by Country
9.1 Middle East and Africa Genetic Engineering Drug Historic Market Size by Country
9.1.1 Middle East and Africa Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Genetic Engineering Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Genetic Engineering Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Genetic Engineering Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Genetic Engineering Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Genetic Engineering Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Shanghai Lansheng Guojian Pharmaceutical
10.1.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
10.1.2 Shanghai Lansheng Guojian Pharmaceutical Introduction and Business Overview
10.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Products Offered
10.1.5 Shanghai Lansheng Guojian Pharmaceutical Recent Development
10.2 Biotech Pharmaceutical
10.2.1 Biotech Pharmaceutical Company Information
10.2.2 Biotech Pharmaceutical Introduction and Business Overview
10.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Biotech Pharmaceutical Genetic Engineering Drug Products Offered
10.2.5 Biotech Pharmaceutical Recent Development
10.3 Anhui Anke Biotechnology
10.3.1 Anhui Anke Biotechnology Company Information
10.3.2 Anhui Anke Biotechnology Introduction and Business Overview
10.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Products Offered
10.3.5 Anhui Anke Biotechnology Recent Development
10.4 GeneScience Pharmaceuticals
10.4.1 GeneScience Pharmaceuticals Company Information
10.4.2 GeneScience Pharmaceuticals Introduction and Business Overview
10.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Products Offered
10.4.5 GeneScience Pharmaceuticals Recent Development
10.5 Beijing SL Pharmaceutical
10.5.1 Beijing SL Pharmaceutical Company Information
10.5.2 Beijing SL Pharmaceutical Introduction and Business Overview
10.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Products Offered
10.5.5 Beijing SL Pharmaceutical Recent Development
10.6 Jiangsu Sihuan Bioengineering
10.6.1 Jiangsu Sihuan Bioengineering Company Information
10.6.2 Jiangsu Sihuan Bioengineering Introduction and Business Overview
10.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Products Offered
10.6.5 Jiangsu Sihuan Bioengineering Recent Development
10.7 Shenzhen Neptunus Interlong Bio-Technique
10.7.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
10.7.2 Shenzhen Neptunus Interlong Bio-Technique Introduction and Business Overview
10.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Products Offered
10.7.5 Shenzhen Neptunus Interlong Bio-Technique Recent Development
10.8 3SBio
10.8.1 3SBio Company Information
10.8.2 3SBio Introduction and Business Overview
10.8.3 3SBio Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 3SBio Genetic Engineering Drug Products Offered
10.8.5 3SBio Recent Development
10.9 Tonghua Dongbao Pharmaceutical
10.9.1 Tonghua Dongbao Pharmaceutical Company Information
10.9.2 Tonghua Dongbao Pharmaceutical Introduction and Business Overview
10.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Products Offered
10.9.5 Tonghua Dongbao Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Genetic Engineering Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Genetic Engineering Drug Industrial Chain Analysis
11.4 Genetic Engineering Drug Market Dynamics
11.4.1 Genetic Engineering Drug Industry Trends
11.4.2 Genetic Engineering Drug Market Drivers
11.4.3 Genetic Engineering Drug Market Challenges
11.4.4 Genetic Engineering Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Genetic Engineering Drug Distributors
12.3 Genetic Engineering Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock